Study Assessing the Effectiveness of a Cardiac Web-based eLearning Platform

Hasselt University1,000 enrolled

Overview

In the trial cardiac patients will be provided with unrestricted access to the web-based eLearing platform for a one-month period.

Patients participating in the trial will be provided with a cardiac web-based eLearning platform for one month during study period. The medical content of the packages will be gathered from a multidisciplinary input of both medics (e.g. cardiologists) and paramedics (e.g. psychologists). E-Learning packages type I: videos with information from caregivers. In these videos, medics and paramedics are interviewed to highlight the etiology, pathophysiology and treatment of coronary artery disease; the associated comorbidities and the ways to prevent recurrence. E-Learning packages type II: videos in which patients are interviewed. Patients can help each other to adhere to their treatment plan, by sharing stories from their own experience about their illness and the rehabilitation afterwards. Short clips of maximum 2 minutes will be provided to study participants.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

1,000

Conditions

Coronary Artery Disease

Interventions

Intervention groupOTHER

The intervention group patients have access to the eLearning platform in addition to conventional cardiac care.The content of platform will be gathered from a multidisciplinary input of both medics (e.g. cardiologists) and paramedics (e.g. psychologists). Patients will also contribute to platform content.

Control groupOTHER

The control group patients receive conventional cardiac care alone.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients suffering from coronary artery disease for which they are treated conservatively, with a percutaneous coronary intervention or with coronary artery bypass grafting Exclusion Criteria: * Patients with dementia or cognitive impairment not being able to sufficiently understand the E-Learning packages content * (Foreign) patients unable to speak Dutch, thereby not being able to understand the content of the E-Learning packages * Patients with advanced visual and/or auditory impairments, hindering them to adequately understand the E-earning packages * Patients participating in another trial during the Pilot study period * Patients refusing to provide signed consent

Locations (2)

ZOL

Genk, Belgium

Jessa Ziekenhuis

Hasselt, Belgium

Outcomes

Primary Outcomes

Health-related quality of life

Health-related quality of life, assessed by HeartQol

Time frame: 3 months

Secondary Outcomes

Adherence to the E-learning packages

Adherence to the E-learning packages as assessed by the number of logs and the cumulative log time on the E-learning platform per patient.

Time frame: 3 months

Effectiveness of E-learning packages

Effectiveness of intervention in improving patients' knowledge of cardiac diseases as assessed by questionnaire scores.

Time frame: 3 months

User experience of eLearning platform

Asses user experience of eLearning platform by User Experience Questionnaire (UEQ)

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.